HR 4772
106th Congress
House
Health
Administrative procedure
Administrative remedies
Civil actions and liability
Class actions (Civil procedure)
Commerce
Crime and Law Enforcement
Damages
Drug industry
Economics and Public Finance
Fines (Penalties)
Government Operations and Politics
Injunctions
Law
Legal fees
Prescription pricing
Price discrimination
Price regulation
Punitive damages
Pharmaceutical Products Price Equity Act
Introduced: June 27, 2000
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 19, 2000
Referred to the Subcommittee on Health and Environment.
Jun 27, 2000
Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 27, 2000
Introduced in House
Plain-English summary
Pharmaceutical Products Price Equity Act - Directs the President to issue such orders and regulations, and establish such procedures and reporting requirements, as the President determines to be appropriate to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions. Authorizes appropriations.
What's happening now
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
3
Cosponsors
1